|
| 36815635 | Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity. | Curr Med Chem | 2024 |
| 38085172 | Bempedoic acid: new evidence and recommendations on use. | Curr Opin Lipidol | 2024 |
| 37964156 | Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review. | Diabetes Ther | 2024 |
| 37751143 | New-Onset Diabetes Mellitus in COVID-19: A Scoping Review. | Diabetes Ther | 2024 |
| 37405714 | Treatment adherence in patients without ST-elevation acute coronary syndrome. | Minerva Cardiol Angiol | 2024 |
| 37038706 | Effects of Trehalose Administration in Patients with Mucopolysaccharidosis Type III. | Curr Med Chem | 2024 |
| 34553653 | Harnessing polyphenol power by targeting eNOS for vascular diseases. | Crit Rev Food Sci Nutr | 2023 |
| 37560745 | The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper. | Arch Med Sci | 2023 |
| 37560738 | Effects of statins on the incidence and outcomes of acute kidney injury in critically ill patients: a systematic review and meta-analysis. | Arch Med Sci | 2023 |
| 37489830 | Position of the Polish Cardiac Society on therapeutic targets for LDL cholesterol concentrations in secondary prevention of myocardial infarctions. | Kardiol Pol | 2023 |
| 38017465 | Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004-2015 cohort studies: no obesity paradox? | Cardiovasc Diabetol | 2023 |
| 37629275 | Management of Coronary Artery Disease in Older Adults: Recent Advances and Gaps in Evidence. | J Clin Med | 2023 |
| 37555441 | The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis. | Eur J Prev Cardiol | 2023 |
| 38058736 | An <i>in vitro</i> investigation of the effects of urolithins A and B on low-density lipoprotein uptake and its regulatory genes. | Arch Med Sci | 2023 |
| 38058727 | The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer. | Arch Med Sci | 2023 |
| 38058712 | 2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024? | Arch Med Sci | 2023 |
| 38058700 | The effects of oral trehalose on glycaemia, inflammation, and quality of life in patients with type 2 diabetes: a pilot randomized controlled trial. | Arch Med Sci | 2023 |
| 37838521 | Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndrome. | J Clin Lipidol | 2023 |
| 37648637 | Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials. | Atherosclerosis | 2023 |
| 37831308 | Rhabdomyolysis or Severe Acute Hepatitis Associated with the Use of Red Yeast Rice Extracts: an Update from the Adverse Event Reporting Systems. | Curr Atheroscler Rep | 2023 |
| 37685628 | Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions. | J Clin Med | 2023 |
| 37822534 | The promise of digital healthcare technologies. | Front Public Health | 2023 |
| 37732047 | Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus<sup>®</sup> and placebo. | Arch Med Sci | 2023 |
| 37732043 | Association between electronic nicotine delivery systems use and risk of stroke: a meta-analysis of 1,024,401 participants. | Arch Med Sci | 2023 |
| 37732042 | The effect of intravenous trehalose administration in a patient with multiple sulfatase deficiency. | Arch Med Sci | 2023 |
| 37641635 | Lipoprotein(a): the enemy that we still don't know how to defeat. | Eur Heart J Open | 2023 |
| 37769437 | Low carbohydrate/ketogenic diet in the optimization of lipoprotein(a) levels: do we have sufficient evidence for any recommendation? | Eur Heart J | 2023 |
| 37676656 | The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019. | JAMA Oncol | 2023 |
| 37671618 | Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL-ACS Data. | J Am Heart Assoc | 2023 |
| 37313196 | Efficacy and safety of sacubitril/valsartan in heart failure compared to renin-angiotensin-aldosterone system inhibitors: a systematic review and meta-analysis of randomised controlled trials. | Arch Med Sci | 2023 |
| 37313195 | A look to the past - what has had the biggest impact on lipids in the last four decades? A personal perspective. | Arch Med Sci | 2023 |
| 37448228 | Eliminating atherosclerotic cardiovascular disease residual risk. | Eur Heart J | 2023 |
| 37144463 | Impact of vitamin D receptor polymorphisms in selected metabolic disorders. | Curr Opin Clin Nutr Metab Care | 2023 |
| 37111334 | Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a). | Pharmaceuticals (Basel) | 2023 |
| 37077903 | The influence of curcumin additives on the viability of probiotic bacteria, antibacterial activity against pathogenic microorganisms, and quality indicators of low-fat yogurt. | Front Nutr | 2023 |
| 37143044 | Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis. | BMC Med | 2023 |
| 37075696 | Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials. | Atherosclerosis | 2023 |
| 37039119 | Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies. | Eur J Prev Cardiol | 2023 |
| 37404744 | Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study. | Front Cardiovasc Med | 2023 |
| 37373853 | Diagnostic Usefulness of Spiroergometry and Risk Factors of Long COVID in Patients with Normal Left Ventricular Ejection Fraction. | J Clin Med | 2023 |
| 37338234 | Prevalence and assessment of risk factors among Polish adults with post-COVID-19 syndrome: a 12-month follow-up study. | Pol Arch Intern Med | 2023 |
| 37273260 | New approaches to reduce recurrent PCI: to angioplasty and beyond! | Eur Heart J Open | 2023 |
| 37006407 | Dietary salt intake and atherosclerosis: an area not fully explored. | Eur Heart J Open | 2023 |
| 37435114 | Distinct Features of Vascular Diseases in COVID-19. | J Inflamm Res | 2023 |
| 37367410 | The Role of Multidisciplinary Approaches in the Treatment of Patients with Heart Failure and Coagulopathy of COVID-19. | J Cardiovasc Dev Dis | 2023 |
| 37299592 | Nutrition, Nutraceuticals and Bioactive Compounds in the Prevention and Fight against Inflammation. | Nutrients | 2023 |
| 37298707 | A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy-A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2023 |
| 37265696 | Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement. | Front Endocrinol (Lausanne) | 2023 |
| 37194635 | Predictors of long-term prognosis based on clinical status and measurements obtained in heart failure patients after 9-week hybrid comprehensive telerehabilitation: A subanalysis of the TELEREH-HF randomized clinical trial. | Kardiol Pol | 2023 |
| 37062814 | Modulation and personalization of therapy after acute coronary syndromes: the road to precision. | Eur Heart J | 2023 |